The effect of statin [HMG CoA reductase inhibitor] use on vascular function in hypertensive subjects.
Phase of Trial: Phase IV
Latest Information Update: 27 May 2010
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 27 May 2010 Procris Pharmaceuticals added as trial sponser as reported by ClnicalTrial.gov record.
- 27 May 2010 Actual patient number (24) added as reported by ClinicalTrials.gov.
- 27 May 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.